ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma

Chen, Yangxia; Hu, Di; Wang, Fang; Huang, Cheng; Xie, Hesong; Jin, Ling*南方医科大学; 1
Aging-US2023-11-15
4阅读
引用收藏
分享

摘要

Glioma remains the most frequent malignancy of the central nervous system. Recently, necroptosis has been identified as a cell death process that mediates the proliferation and development of tumor cells. LncRNAs play a key role in the diagnosis and treatment of various diseases. However, the impact that necrosis-related lncRNAs (NRLs) have on glioma remains unclear. In our studies, we selected 9 NRLs to construct a prognostic model. Meanwhile, we assessed the survival curves of these 9 NRLs. Our findings found ADGRA1-AS1 and WAC-AS1 were protective lncRNAs, while MIR210HG, LINC01503, CRNDE, HOXC-AS1, ZIM2-AS1, MIR22HG and PLBD1-AS1 were risk lncRNAs. Specifically, 12 immune cells, 25 immune-correlated pathways, and TME score were differentially expressed in the both risk groups. Additionally, the study predicted and validated the necroptosisrelated lncRNA CRNDE/miR-23b-3p/IDH1 axis. CRNDE was strongly expressed in glioma specimens and several cell lines. Inhibiting CRNDE resulted in a substantial reduction in the proliferation and migration of U-118MG and U251 cells. Furthermore, the study predicted that CRNDE may exhibit oncogenic features by adsorbing miR-23b3p and positively regulating IDH1 expression. Overall, the study constructed a prognostic model in glioma, and predicted a lncRNA CRNDE/miR-23b-3p/IDH1 axis, which could potentially be useful for gene therapy of glioma.

学科与关键词

关键词
gliomanecroptosislncRNA CRNDEmiR-23b-3pIDH1
相关
加载中…
  • Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
    Chen, Desheng; Dou, Chao; Liu, Haiyu; Xu, Binshun; Hu, Bowen; Kuang, Liangwen; Yao, Jiawei; Zhao, Yan; Yu, Shan; Li, Yang; Wang, Fuqing*; Guo, Mian*Frontiers in Oncology, 2022, 12: 929233.被引 4
  • A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
    Song, Chong; Zhu, Liwen; Gu, Junwei; Wang, Tong; Shi, Linyong; Li, Chiyang; Chen, Lei; Xie, Sidi*; Lu, Yuntao*Frontiers in Oncology, 2022, 12: 1024208.被引 2
  • A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma
    Yuan, Ying-Shi; Jin, Xin; Chen, Lu; Liao, Jia-Min; Zhang, Yang; Yu, Ke-Wei; Li, Wei-Kang; Cao, Shun-Wang; Huang, Xian-Zhang*; Kang, Chun-Min*Frontiers in Immunology, 2022, 13: 1027794.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Aging-US
发表日期
2023-11-15
卷期
第 15 卷, 第 21 期
页码
12296-12313
语言
ENGLISH
成果收录
SCIE
资助标注
FUNDING; National Natural Science Foundation of China [81900160]; General Program of Natural Science Foundation of Guangdong Province [2023A1515010015]

作者

  • C

    Chen, Yangxia (第一作者)

    1 · southern med univ

  • H

    Hu, Di

    1

查看全部 6 位作者收起作者
  • W

    Wang, Fang

    1

  • H

    Huang, Cheng

    1

  • X

    Xie, Hesong

    1

  • J

    Jin, Ling (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417